Skip to menu Skip to content Skip to footer

From iPSC based disease discovery for HBSL to novel therapeutic approaches for leukodystrophies (2014-2018)

Experts

Professor Ernst Wolvetang

Senior Group Leader
Australian Institute for Bioengineering and Nanotechnology
Ernst Wolvetang
Ernst Wolvetang